213 related articles for article (PubMed ID: 23274577)
1. Incidence of periprocedural myocardial infarction and cardiac biomarker testing after percutaneous coronary intervention in Japan: results from a multicenter registry.
Arai T; Yuasa S; Miyata H; Kawamura A; Maekawa Y; Ishikawa S; Noma S; Inoue S; Sato Y; Kohsaka S; Fukuda K
Heart Vessels; 2013 Nov; 28(6):714-9. PubMed ID: 23274577
[TBL] [Abstract][Full Text] [Related]
2. Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.
Ishibashi Y; Muramatsu T; Nakatani S; Sotomi Y; Suwannasom P; Grundeken MJ; Cho YK; Garcia-Garcia HM; van Boven AJ; Piek JJ; Sabaté M; Helqvist S; Baumbach A; McClean D; de Sousa Almeida M; Wasungu L; Miquel-Hebert K; Dudek D; Chevalier B; Onuma Y; Serruys PW
JACC Cardiovasc Interv; 2015 Jul; 8(8):1053-1063. PubMed ID: 26205444
[TBL] [Abstract][Full Text] [Related]
3. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
Stetler J; Karatasakis A; Christakopoulos GE; Tarar MN; Amsavelu S; Patel K; Rangan BV; Roesle M; Resendes E; Grodin J; Abdullah S; Banerjee S; Brilakis ES
Catheter Cardiovasc Interv; 2016 Jul; 88(1):1-6. PubMed ID: 27014962
[TBL] [Abstract][Full Text] [Related]
4. Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.
Lo N; Michael TT; Moin D; Patel VG; Alomar M; Papayannis A; Cipher D; Abdullah SM; Banerjee S; Brilakis ES
JACC Cardiovasc Interv; 2014 Jan; 7(1):47-54. PubMed ID: 24332422
[TBL] [Abstract][Full Text] [Related]
5. Correlates and outcomes related to periprocedural myocardial injury during percutaneous coronary intervention for chronic total occlusion: Results from a prospective, single center PCI registry.
Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Kirtane AJ; Zhang RY
Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():616-23. PubMed ID: 26864270
[TBL] [Abstract][Full Text] [Related]
6. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
[TBL] [Abstract][Full Text] [Related]
7. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
Kim JH; Kim BK; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2018 Sep; 92(3):477-485. PubMed ID: 29266736
[TBL] [Abstract][Full Text] [Related]
8. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
9. Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug-eluting stent.
Chen SL; Zhang JJ; Ye F; Tian NL; Sheiban I; Jepson N; Paiboon C; Sansoto T; Kwan TW; Wen SY; Wang HC; Jiang TM; Wang Y; Chen LL; Qiu CG; Zhang YJ; Chen MX; De Maria A
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():696-705. PubMed ID: 25631678
[TBL] [Abstract][Full Text] [Related]
10. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study.
Christensen MK; Huang H; Torp-Pedersen C; Trydal T; Ravkilde J
BMC Cardiovasc Disord; 2016 Jun; 16():140. PubMed ID: 27305902
[TBL] [Abstract][Full Text] [Related]
11. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention.
Garcia-Garcia HM; McFadden EP; von Birgelen C; Rademaker-Havinga T; Spitzer E; Kleiman NS; Cohen DJ; Kennedy KF; Camenzind E; Mauri L; Steg PG; Wijns W; Silber S; van Es GA; Serruys PW; Windecker S; Cutlip D; Vranckx P
JACC Cardiovasc Interv; 2019 Oct; 12(19):1954-1962. PubMed ID: 31601389
[TBL] [Abstract][Full Text] [Related]
12. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.
Kang MG; Kang Y; Jang HG; Kim K; Koh JS; Park JR; Hwang SJ; Hwang JY; Bae JS; Ahn JH; Jang JY; Park Y; Jeong YH; Kwak CH; Park HW
Coron Artery Dis; 2018 Nov; 29(7):589-596. PubMed ID: 29965838
[TBL] [Abstract][Full Text] [Related]
14. Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study.
Guerra E; Hadamitzky M; Ndrepepa G; Bauer C; Ibrahim T; Ott I; Laugwitz KL; Schunkert H; Kastrati A
Int J Cardiovasc Imaging; 2014 Aug; 30(6):1087-95. PubMed ID: 24781031
[TBL] [Abstract][Full Text] [Related]
15. Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.
Idris H; Lo S; Shugman IM; Saad Y; Hopkins AP; Mussap C; Leung D; Thomas L; Juergens CP; French JK
J Am Heart Assoc; 2014 Oct; 3(6):e001086. PubMed ID: 25359403
[TBL] [Abstract][Full Text] [Related]
16. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
Bressi E; Mangiacapra F; Ricottini E; Cavallari I; Colaiori I; Di Gioia G; Creta A; Di Sciascio G
Am J Cardiol; 2016 Oct; 118(7):980-4. PubMed ID: 27515894
[TBL] [Abstract][Full Text] [Related]
17. Determinants and Prognostic Significance of Periprocedural Myocardial Injury in Patients With Successful Percutaneous Chronic Total Occlusion Interventions.
Lee SW; Lee PH; Kang SH; Choi H; Chang M; Roh JH; Yoon SH; Ahn JM; Park DW; Kang SJ; Kim YH; Lee CW; Park SW; Park SJ
JACC Cardiovasc Interv; 2016 Nov; 9(21):2220-2228. PubMed ID: 27832848
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
19. Incidence, predictors and longer-term impact of troponin elevation following hybrid chronic total occlusion percutaneous coronary intervention.
Dautov R; Ybarra LF; Nguyen CM; Gibrat C; Joyal D; Rinfret S
Catheter Cardiovasc Interv; 2018 Nov; 92(5):E308-E316. PubMed ID: 29481724
[TBL] [Abstract][Full Text] [Related]
20. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
Cho MS; Ahn JM; Lee CH; Kang DY; Lee JB; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Aug; 10(15):1498-1507. PubMed ID: 28797425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
